Quench Bio scores $50 mln Series A
Cambridge, Massachusetts-based Quench Bio, a biotechnology company focused on severe inflammatory diseases, has raised $50 million in Series A funding.
Cambridge, Massachusetts-based Quench Bio, a biotechnology company focused on severe inflammatory diseases, has raised $50 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination